Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Krystal Biotech, Inc. Stock Halal?
Shariah Compliance Analysis of KRYS Stock
United States Health Care Mid Cap No. As of November 2026, Krystal Biotech, Inc. (KRYS) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Krystal Biotech, Inc. does not pass Musaffa's business and financial screening criteria.
Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. The company is headquartered in Pittsburgh, Pennsylvania and currently employs 295 full-time employees. The company went IPO on 2017-09-20. The firm is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.
KRYS Shariah Compliance
Screening Methodology: AAOIFI
As of November 2026, Krystal Biotech, Inc. is classified as not halal.
NOT HALALKrystal Biotech, Inc. (KRYS) Chart
Fetching Price Chart...
Financial Metrics & Statements of Krystal Biotech, Inc. (KRYS)
FAQ's for Krystal Biotech, Inc. (KRYS)
- As of November 2026, Krystal Biotech, Inc. KRYS is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Krystal Biotech, Inc. using these criteria to determine its compliance status.
- Muslim investors may consider investing in Krystal Biotech, Inc. if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Krystal Biotech, Inc. by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Krystal Biotech, Inc. may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Krystal Biotech, Inc. on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Krystal Biotech, Inc. (KRYS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
